Injectable nanosuspension based on orthoester for synergistic chemo-photothermal/gas therapy in localized cancer treatment
Colloids and Surfaces B: Biointerfaces · 2025
DOI: 10.1016/j.colsurfb.2025.114841 ↗Kurz gefasst
Video/Audio in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2025. Verfasst von Yuping Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, 111…. Hauptthemen laut MEDLINE: Nanoparticle Drug Delivery System, Esters, Biomimetic Materials, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, National Natural Science Foundation of China, Scientific Research Foundation of Education Department of Anhui Province of China.
Abstract (Originalsprache)
Localized drug delivery system possesses significant potential for enhancing therapeutic efficacy by maximizing drug accumulation at tumor sites while minimizing systemic toxicity. In this study, we developed an injectable pH-responsive nanosuspension (OE-I-m@MTA) integrating chemotherapy, photothermal therapy, and nitric oxide (NO)-mediated gas therapy. An orthoester compound (OE) was synthesized as a liquid excipient. Mitoxantrone (MIT) and the NO donor L-arginine (L-Arg) were loaded into mesoporous silica nanoparticles (MSN), which were further encapsulated by H22 tumor cell membranes to give a biomimetic nanoparticles (m@MTA). Subsequently, m@MTA and indocyanine green (ICG) were dispersed within the OE matrix to form an injectable nanosuspension (OE-I-m@MTA). Upon peritumoral injection, the OE component demonstrated dual advantages: pH-responsive dissolution in the acidic tumor microenvironment and enhanced tissue permeability, synergistically promoting deep tumor penetration of the biomimetic nanoparticles. Under 808 nm laser irradiation, OE-I-m@MTA exhibited triple therapeutic effects, effectively inhibiting the proliferation of cancer cells. This multimodal approach achieved remarkable tumor suppression, with a tumor growth inhibition rate of 93.86 %. The orthoester based nanosuspension provide a novel combinatorial therapeutic paradigm for localized cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, 111 Jiulong Road, Hefei, Anhui Province 230601, PR China.
- Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, 111 Jiulong Road, Hefei, Anhui Province 230601, PR China. Electronic addr…
Förderung
- Natural Science Foundation of Anhui Province
- National Natural Science Foundation of China
- Scientific Research Foundation of Education Department of Anhui Province of China
Zitieren
APA
Yang, Y., Zhang, Z., Shi, Z., Liang, Z., Yang, Q., Yang, X., Yan, G., Wang, X., & Tang, R. (2025). Injectable nanosuspension based on orthoester for synergistic chemo-photothermal/gas therapy in localized cancer treatment. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2025.114841
Vancouver
Yang Y, Zhang Z, Shi Z, Liang Z, Yang Q, Yang X, et al. Injectable nanosuspension based on orthoester for synergistic chemo-photothermal/gas therapy in localized cancer treatment. Colloids and Surfaces B: Biointerfaces. 2025. doi:10.1016/j.colsurfb.2025.114841
BibTeX
@article{Yang2025,
author = {Yang, Yuping and Zhang, Ziyun and Shi, Zuoao and Liang, Zihan and Yang, Qirong and Yang, Xuefeng and Yan, Guoqing and Wang, Xin and Tang, Rupei},
title = {Injectable nanosuspension based on orthoester for synergistic chemo-photothermal/gas therapy in localized cancer treatment},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2025},
doi = {10.1016/j.colsurfb.2025.114841}
}
EUVIMED